Maxim raised the firm’s price target on INmune Bio (INMB) to $30 from $22 and keeps a Buy rating on the shares. The company’s announcement related to positive data for a stem cell-based therap ...

Bio-Path (BPTH) Holdings provides an update from the Company’s ongoing Phase 1/1b clinical trial of BP1001-A in solid tumor patients and reports continued patient progress from the Company’s ...

Discover the Top 20 best Fashion Logos that define style in the industry! From iconic to innovative, explore how these logos captivate audiences! In fashion, logos are more than just symbols; they are ...